SCHENK DALE B has a total of 31 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are RHYTHM PHARMACEUTICALS INC, BIOCELLS BEIJING BIOTECH CO LTD and GRANDI GUIDO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 26 | |
#2 | Australia | 2 | |
#3 | Canada | 1 | |
#4 | Japan | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Machines | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Unspecified technologies | |
#6 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Schenk Dale B | 31 |
#2 | Seubert Peter A | 11 |
#3 | Games Kate Dora | 7 |
#4 | Masliah Eliezer | 6 |
#5 | Buttini Manuel J | 6 |
#6 | Rockenstein Edward | 6 |
#7 | Schlossmacher Michael G | 5 |
#8 | Chilcote Tamie J | 5 |
#9 | Vigo-Pelfrey Carmen | 5 |
#10 | Selkoe Dennis J | 5 |
Publication | Filing date | Title |
---|---|---|
US2014050733A1 | Apoe immunotherapy | |
US2012142902A1 | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease | |
US2010086545A1 | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
US2009208487A1 | Treatment and delay of outset of synucleinopathic and amyloidogenic disease | |
US2006058233A1 | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
US2005037013A1 | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
AU7322398A | Methods and compositions for the detection of soluble beta-amyloid peptide | |
WO9410569A1 | METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE |